Search
forLearn
1 / 1 resultsResearch
5 / 1000+ results![129 Genetic transformation of keratoacanthoma-type cutaneous squamous cell carcinoma following intralesional chemotherapy](/images/research/60b1bc6c-3a54-4ce0-a7b6-9562d59ceb87/small/13529.jpg)
research 129 Genetic transformation of keratoacanthoma-type cutaneous squamous cell carcinoma following intralesional chemotherapy
Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.
![Malignant epithelial tumors: Part II. Therapy and prevention](/images/research/55289e9e-463f-4eb6-b1c0-b625a05422fe/small/25968.jpg)
research Malignant epithelial tumors: Part II. Therapy and prevention
The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.
![131 Mutational landscape of extramammary Paget disease](/images/research/eb3610e3-933b-45c0-800c-c44c54108cd1/small/13659.jpg)
research 131 Mutational landscape of extramammary Paget disease
The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.
![Intralesional therapy for the treatment of keratoacanthoma](/images/research/21a84b01-cd00-4e26-83a8-cdc91dc93aba/small/33390.jpg)
research Intralesional therapy for the treatment of keratoacanthoma
Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.
![130 Expression of nidogen1 in basal cell carcinoma](/images/research/cc133987-62c9-4aaf-b00b-874d4a911bf9/small/13667.jpg)
research 130 Expression of nidogen1 in basal cell carcinoma
Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.
Community Join
1 / 1 resultscommunity 2020 Hair and Scalp Treatments: A Clinical Guide (in Depth 350 Page Guide)
Treatments for hair loss, including topical immunotherapy, regenerative treatments, laser and light-based therapies, oral supplements, intralesional steroids, and new drugs like finasteride and minoxidil.